Patient Medication Adherence Metrics | Adherence, Persistence, and Compliance Rates

STUDY OVERVIEW
BENCHMARK CLASS
SPECIAL OFFER

Non-members: Click here to review a complimentary excerpt from “Improving Patient Medication Adherence Metrics: Adherence, Persistence, and Compliance Rates”

STUDY OVERVIEW

The growth of specialty pharmacies and the expansion of patient support hub services have led to an abundance of patient touchpoints, but without a commensurate industry-wide increase in adherence rates.

Various factors such as reimbursement denials, sticker shock at the pharmacy counter, and pharmacy switching can all contribute to stagnation in adherence rates, but what are pharmaceutical and biotech companies doing to isolate and increase adherence?

Best Practices, LLC undertook this research to establish industry benchmarks around patient medication adherence rates. The study delivers industry benchmarks around complex patient medication adherence metrics such as Adherence, Persistence, and Compliance Rates.

KEY TOPICS

Tracking Complex Patient Medication Adherence Metrics: Adherence, Persistence, and Compliance Rates
Average Adherence Rates and Zone of Competitive Effectiveness
Oral Adherence Industry Case Studies

KEY METRICS

Do benchmark organizations track Adherence, Persistence, and Compliance, and does their definition of those metrics align with that of standard definitions used in this study?
Types of adherence metrics collected by benchmark organizations
Average patient medication adherence rates and zone of competitive effectiveness

SAMPLE KEY FINDINGS

Average Adherence Rates: Average adherence rates for brands typically fall between 60% and 90%.

METHODOLOGY

Best Practices, LLC engaged 27 leaders from 20 pharmaceutical and biotech companies in this research through a benchmarking survey.

Industries Profiled:
Consulting; Pharmaceutical; Biopharmaceutical; Biotech; Chemical; Health Care; Communications; Consumer Products; Medical Device

Companies Profiled:
Coeus Consulting; Daiichi Sankyo; Eli Lilly; Emmaus Life Sciences; Genentech; GlaxoSmithKline ; Jazz Pharmaceuticals; Medunik; Myovant Sciences; NexGen Healthcare Communications; Novartis; Novo Nordisk; Patheon; Priovant Therapeutics; Roche; Sandoz; Servier; Spectrum Pharmacy Products; Teva Pharmaceutical Industries Ltd; UCB Pharma

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.

Improving Patient Medication Adherence Metrics: Adherence, Persistence, and Compliance Rates

ID: 5716

Features:

Pages/Slides: 35

Published: 2022

Delivery Format: Online PDF Document

RELATED RESEARCH

1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6F00F963636DB3F93002587E600216819
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-improving-patient-medication-adherence-metrics-persistence-compliance-rates?opendocument
18
19opendocument
2044.222.134.250
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB